Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital

Background: Ventilator-associated pneumonia (VAP) is the most frequent intensive care unit (ICU)-acquired infection. The etiology of VAP and their antimicrobial susceptibility pattern varies with different patient populations and types of ICUs. Materials and Methods: An observational cross-sectional...

Full description

Bibliographic Details
Main Authors: Somi Patro, Gitanjali Sarangi, Padma Das, Ashoka Mahapatra, Dharitri Mohapatra, Bimoch Projna Paty, Nirupama Chayani
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2018;volume=61;issue=3;spage=375;epage=379;aulast=Patro
_version_ 1818391945247981568
author Somi Patro
Gitanjali Sarangi
Padma Das
Ashoka Mahapatra
Dharitri Mohapatra
Bimoch Projna Paty
Nirupama Chayani
author_facet Somi Patro
Gitanjali Sarangi
Padma Das
Ashoka Mahapatra
Dharitri Mohapatra
Bimoch Projna Paty
Nirupama Chayani
author_sort Somi Patro
collection DOAJ
description Background: Ventilator-associated pneumonia (VAP) is the most frequent intensive care unit (ICU)-acquired infection. The etiology of VAP and their antimicrobial susceptibility pattern varies with different patient populations and types of ICUs. Materials and Methods: An observational cross-sectional study was performed over a period of 2 years in a tertiary care hospital to determine the various etiological agents causing VAP and to detect the presence of multidrug-resistant (MDR) pathogens in these VAP patients. Combination disk method, Modified Hodge test, ethylenediaminetetraacetic acid disk synergy test, and AmpC disk test were performed for the detection of extended-spectrum beta-lactamase (ESBL), carbapenemases, metallo-beta-lactamases (MBL), and AmpC beta-lactamases, respectively. Results: The prevalence of VAP was 35%. Enterobacteriaceae (66.66%) and Staphylococcus aureus (20%) were common in early-onset VAP, while nonfermenters (50%) and Enterobacteriaceae (40.61%) were predominant from late-onset VAP. Nearly 60.87% of the bacterial pathogens were MDR. ESBL was produced by 21.74% of Enterobacteriaceae. AmpC β-lactamase was positive in 35.29% nonfermenters and 26.08% Enterobacteriaceae. MBL was positive in 17.64% nonfermenters and 17.39% Enterobacteriaceae. Among the S. aureus isolates, 75% were cefoxitin resistant. Prior antibiotic therapy (P = 0.001) and hospitalization of 5 days or more (P = 0.001) were independent risk factors for VAP by MDR pathogens. polymyxin B, tigecycline, and vancomycin were the most sensitive drugs for Gram-negative and positive isolates respectively from VAP. Statistical Analysis: SPSS for Windows Version SPSS 17.0 (SPSS Inc., Chicago, IL, USA) and Chi-square with Yates correction. Conclusion: Late-onset VAP is increasingly associated with MDR pathogens. Treatment with polymyxin B, tigecycline, and vancomycin should be kept as last-line reserve drugs against most of the MDR pathogens.
first_indexed 2024-12-14T05:21:35Z
format Article
id doaj.art-f62a7e63c0ed4f94820c83c6ab7ab464
institution Directory Open Access Journal
issn 0377-4929
language English
last_indexed 2024-12-14T05:21:35Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj.art-f62a7e63c0ed4f94820c83c6ab7ab4642022-12-21T23:15:39ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292018-01-0161337537910.4103/IJPM.IJPM_487_16Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospitalSomi PatroGitanjali SarangiPadma DasAshoka MahapatraDharitri MohapatraBimoch Projna PatyNirupama ChayaniBackground: Ventilator-associated pneumonia (VAP) is the most frequent intensive care unit (ICU)-acquired infection. The etiology of VAP and their antimicrobial susceptibility pattern varies with different patient populations and types of ICUs. Materials and Methods: An observational cross-sectional study was performed over a period of 2 years in a tertiary care hospital to determine the various etiological agents causing VAP and to detect the presence of multidrug-resistant (MDR) pathogens in these VAP patients. Combination disk method, Modified Hodge test, ethylenediaminetetraacetic acid disk synergy test, and AmpC disk test were performed for the detection of extended-spectrum beta-lactamase (ESBL), carbapenemases, metallo-beta-lactamases (MBL), and AmpC beta-lactamases, respectively. Results: The prevalence of VAP was 35%. Enterobacteriaceae (66.66%) and Staphylococcus aureus (20%) were common in early-onset VAP, while nonfermenters (50%) and Enterobacteriaceae (40.61%) were predominant from late-onset VAP. Nearly 60.87% of the bacterial pathogens were MDR. ESBL was produced by 21.74% of Enterobacteriaceae. AmpC β-lactamase was positive in 35.29% nonfermenters and 26.08% Enterobacteriaceae. MBL was positive in 17.64% nonfermenters and 17.39% Enterobacteriaceae. Among the S. aureus isolates, 75% were cefoxitin resistant. Prior antibiotic therapy (P = 0.001) and hospitalization of 5 days or more (P = 0.001) were independent risk factors for VAP by MDR pathogens. polymyxin B, tigecycline, and vancomycin were the most sensitive drugs for Gram-negative and positive isolates respectively from VAP. Statistical Analysis: SPSS for Windows Version SPSS 17.0 (SPSS Inc., Chicago, IL, USA) and Chi-square with Yates correction. Conclusion: Late-onset VAP is increasingly associated with MDR pathogens. Treatment with polymyxin B, tigecycline, and vancomycin should be kept as last-line reserve drugs against most of the MDR pathogens.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2018;volume=61;issue=3;spage=375;epage=379;aulast=PatroMultidrug resistantrisk factorsventilator-associated pneumonia
spellingShingle Somi Patro
Gitanjali Sarangi
Padma Das
Ashoka Mahapatra
Dharitri Mohapatra
Bimoch Projna Paty
Nirupama Chayani
Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital
Indian Journal of Pathology and Microbiology
Multidrug resistant
risk factors
ventilator-associated pneumonia
title Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital
title_full Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital
title_fullStr Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital
title_full_unstemmed Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital
title_short Bacteriological profile of ventilator-associated pneumonia in a tertiary care hospital
title_sort bacteriological profile of ventilator associated pneumonia in a tertiary care hospital
topic Multidrug resistant
risk factors
ventilator-associated pneumonia
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2018;volume=61;issue=3;spage=375;epage=379;aulast=Patro
work_keys_str_mv AT somipatro bacteriologicalprofileofventilatorassociatedpneumoniainatertiarycarehospital
AT gitanjalisarangi bacteriologicalprofileofventilatorassociatedpneumoniainatertiarycarehospital
AT padmadas bacteriologicalprofileofventilatorassociatedpneumoniainatertiarycarehospital
AT ashokamahapatra bacteriologicalprofileofventilatorassociatedpneumoniainatertiarycarehospital
AT dharitrimohapatra bacteriologicalprofileofventilatorassociatedpneumoniainatertiarycarehospital
AT bimochprojnapaty bacteriologicalprofileofventilatorassociatedpneumoniainatertiarycarehospital
AT nirupamachayani bacteriologicalprofileofventilatorassociatedpneumoniainatertiarycarehospital